Scotland and Switzerland each combine good academic research with entrepreneurial encouragement in the form of venture capital and government initiatives. Their burgeoning biotechnology businesses prove that it can be a magic combination.
Biotechnology in Europe is not all bad news. With the debate over genetically modified organisms, the continent seems to be a hostile environment for biotechnology of any kind. But as I learned in two recent visits, positive steps are being taken in European biotech research and commercialization.
This past fall, I took two whirlwind European tours: first in Scotland's `Tartan Triangle" of Glasgow, Edinburgh, and Dundee and then in …
No comments:
Post a Comment